Anne Watrin

Anne WATRIN is a seasoned Clinical & Regulatory Affairs professional with extensive experience in managing Investigational Device Exemption (IDE) processes for Class III medical devices at ONWARD since October 2016. WATRIN has successfully overseen clinical trial submissions across Europe, the US, and Canada, demonstrating expertise in all phases of clinical trials, including Early Feasibility, Feasibility, and Pivotal studies. Previous roles include Director of Clinical affairs and Clinical Program Manager, focusing on clinical strategy and evaluation for active implantable medical devices. WATRIN's earlier experience also includes positions as a Senior Regulatory Affairs Engineer and Regulatory Affairs Engineer at GSK, where responsibilities included updating technical files and preparing for audits. Educational qualifications encompass a Diplôme d'ingénieur in Biomedical Engineering from ISIFC, alongside degrees in Biochemistry from Université Laval and Université de Franche-Comté. Additionally, WATRIN has pursued crisis management training.